Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4093894

O=C(CN1CCCC1)Nc1ccc(Cl)c(NC2=NC(=O)C(=Cc3ccc4ncccc4c3)S2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
TERT O14746 1/20 0.38
DYRK3 O43781 2/20 0.38
MAPK10 P53779 2/20 0.37
EGFR P00533 1/20 0.37
HPGD P15428 1/20 0.37
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
PIK3CD O00329 1/20 0.36
PIM1 P11309 1/20 0.36
CSNK2A2 P19784 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CG P48736 1/20 0.36
CLK1 P49759 1/20 0.36
CLK3 P49761 1/20 0.36
CSNK2B P67870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4093888 1.00 OGA (0.40) OGAALDH1A1MAPTLMNAGAA
Trifluoroacetic Acid SCHEMBL4091128 0.99 OGA (0.39) OGAALDH1A1MAPTLMNAGAA
Trifluoroacetic Acid SCHEMBL4091117 0.99 OGA (0.39) OGAALDH1A1MAPTLMNAGAA
SCHEMBL2985523 0.95 OGA (0.43) OGAALDH1A1TERTDYRK3MAPK10
SCHEMBL2985521 0.95 OGA (0.43) OGAALDH1A1TERTDYRK3MAPK10
Trifluoroacetic Acid SCHEMBL4102095 0.95 OGA (0.39) OGAALDH1A1MAPTLMNAGAA
Trifluoroacetic Acid SCHEMBL4102103 0.95 OGA (0.39) OGAALDH1A1MAPTLMNAGAA
SCHEMBL3641881 0.94 OGA (0.42) OGATERTDYRK3MAPK10EGFR
SCHEMBL3641882 0.94 OGA (0.42) OGATERTDYRK3MAPK10EGFR
Trifluoroacetic Acid SCHEMBL4095073 0.94 WNT3A (0.40) OGAALDH1A1MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 OGA 1432/4885ALDH1A1 4089/4885MAPT 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.